JP2019509064A5 - - Google Patents

Download PDF

Info

Publication number
JP2019509064A5
JP2019509064A5 JP2018568189A JP2018568189A JP2019509064A5 JP 2019509064 A5 JP2019509064 A5 JP 2019509064A5 JP 2018568189 A JP2018568189 A JP 2018568189A JP 2018568189 A JP2018568189 A JP 2018568189A JP 2019509064 A5 JP2019509064 A5 JP 2019509064A5
Authority
JP
Japan
Prior art keywords
protein
synthetic
sequence
mutanase
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018568189A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019509064A (ja
JP7145083B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/023263 external-priority patent/WO2017165320A1/en
Publication of JP2019509064A publication Critical patent/JP2019509064A/ja
Publication of JP2019509064A5 publication Critical patent/JP2019509064A5/ja
Application granted granted Critical
Publication of JP7145083B2 publication Critical patent/JP7145083B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018568189A 2016-03-20 2017-03-20 高等植物の葉緑体におけるトランス遺伝子発現を増加させるためのコドン最適化及びリボソームプロファイリング Active JP7145083B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662310788P 2016-03-20 2016-03-20
US62/310,788 2016-03-20
PCT/US2017/023263 WO2017165320A1 (en) 2016-03-20 2017-03-20 Codon optimization and ribosome profiling for increasing transgene expression in chloroplasts of higher plants

Publications (3)

Publication Number Publication Date
JP2019509064A JP2019509064A (ja) 2019-04-04
JP2019509064A5 true JP2019509064A5 (https=) 2020-04-02
JP7145083B2 JP7145083B2 (ja) 2022-09-30

Family

ID=59899714

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018568189A Active JP7145083B2 (ja) 2016-03-20 2017-03-20 高等植物の葉緑体におけるトランス遺伝子発現を増加させるためのコドン最適化及びリボソームプロファイリング

Country Status (6)

Country Link
US (1) US11332754B2 (https=)
EP (1) EP3432902B8 (https=)
JP (1) JP7145083B2 (https=)
CN (1) CN110603046B (https=)
CA (1) CA3055900A1 (https=)
WO (1) WO2017165320A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7249149B2 (ja) * 2016-05-12 2023-03-30 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア バイオフィルムの堆積および産生を阻害するための組成物および方法
JP2021534754A (ja) * 2018-08-22 2021-12-16 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア レタス葉緑体で抗生物質フリーのバイオ医薬品を製造するための組成物および方法
CN112195226B (zh) * 2019-07-08 2022-05-24 清华大学 极小量细胞核糖体保护的rna片段测序的方法
CN111635935A (zh) * 2020-06-10 2020-09-08 华中农业大学 一种低成本、高通量间接量化蛋白表达水平的方法及其应用
CN120266212A (zh) * 2022-11-24 2025-07-04 南京金斯瑞生物科技有限公司 密码子优化
CN117511978B (zh) * 2024-01-08 2024-03-22 深圳粒影生物科技有限公司 一种提高外源蛋白表达量的方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946676A (en) * 1986-08-27 1990-08-07 De Staat Der Nederlanden Vaccine comprising an immunogenic protein and, as an adjuvant, a substantially non-immunogenic, sequentially homologous peptide
JPH10201483A (ja) * 1996-11-25 1998-08-04 Lion Corp ムタナーゼ遺伝子
US7741536B2 (en) * 1997-08-07 2010-06-22 University Of Central Florida Research Foundation, Inc. Expression of human serum albumin in plastids
US20110179530A1 (en) * 2001-01-23 2011-07-21 University Of Central Florida Research Foundation, Inc. Pharmaceutical Proteins, Human Therapeutics, Human Serum Albumin Insulin, Native Cholera Toxin B Subunit on Transgenic Plastids
NL1009834C2 (nl) * 1998-08-10 2000-02-11 Stanislaus Laurens Johan Woute Antistoffen voor toepassing in de gerichte en tijdelijke behandeling van mens en dier.
BR9915919A (pt) * 1998-10-07 2001-08-21 Syngenta Participations Ag Proteìnas terapeuticamente ativas em plantas
CN1886512A (zh) * 2002-04-23 2006-12-27 斯克里普斯研究所 多肽在叶绿体中的表达以及用于表达多肽的组合物和方法
JP2005185182A (ja) * 2003-12-25 2005-07-14 Lion Corp α−1,3−グルコオリゴ糖の製造方法、該製造方法により得られるα−1,3−グルコオリゴ糖およびこれを含有する製剤組成物
WO2007055789A2 (en) * 2005-10-31 2007-05-18 Neose Technologies, Inc. Expression of soluble therapeutic proteins
WO2007133558A2 (en) * 2006-05-09 2007-11-22 The Scripps Research Institute Robust expression of a bioactive mammalian protein in chlamydomonas chloroplast
CA2887752C (en) * 2007-04-03 2020-03-24 Vib Vzw Glycosylation of molecules
GB0911870D0 (en) 2009-07-08 2009-08-19 Ucl Business Plc Optimised coding sequence and promoter
US8326547B2 (en) * 2009-10-07 2012-12-04 Nanjingjinsirui Science & Technology Biology Corp. Method of sequence optimization for improved recombinant protein expression using a particle swarm optimization algorithm
WO2011063284A1 (en) * 2009-11-19 2011-05-26 Sapphire Energy, Inc. Production of therapeutic proteins in photosynthetic organisms
EP3508573A1 (en) 2010-07-09 2019-07-10 Bioverativ Therapeutics Inc. Systems for factor viii processing and methods thereof
CN102146344A (zh) * 2010-11-02 2011-08-10 上海师范大学 优化密码子提高外源基因表达量和莱茵衣藻制氢量的方法
US10865419B2 (en) * 2011-10-24 2020-12-15 The Trustees Of The University Of Pennsylvania Orally administered plastid expressed cholera toxin B subunit-exendin 4 as treatment for type 2 diabetes
WO2013170031A1 (en) * 2012-05-09 2013-11-14 The Regents Of The University Of California Method for in silico modeling of gene product expression and metabolism
WO2014127215A1 (en) 2013-02-15 2014-08-21 Biogen Idec Ma Inc. Optimized factor viii gene
PT3068869T (pt) * 2013-11-15 2020-10-08 Univ Pennsylvania Composições para supressão da formação de inibidores contra fator viii em pacientes de hemofilia a

Similar Documents

Publication Publication Date Title
JP2019509064A5 (https=)
ES2761693T3 (es) Composiciones y métodos para mejorar las respuestas inmunitarias a Eimeria
RU2016146801A (ru) Вакцинная композиция против инфекции, вызванной streptococcus suis
US7901691B2 (en) Chimeric G protein based rabies vaccine
FR2990699A1 (fr) Cassettes d'expression procaryotes regulees par le stress
JP2009535306A5 (https=)
Matsuo et al. Development of Cucumber mosaic virus as a vector modifiable for different host species to produce therapeutic proteins
KR20180083904A (ko) 면역원성이 증강된 백신 항원
CN102037135A (zh) 增强对有鞭毛的细菌的免疫反应的组合物和方法
CN112135630B (zh) 猪瘟疫苗组合物及其制备方法
Zhao et al. Surface display of hirame novirhabdovirus (HIRRV) G protein in Lactococcus lactis and its immune protection in flounder (Paralichthys olivaceus)
US11332754B2 (en) Codon optimization for increasing transgene expression in chloroplasts of higher seed plants
US20030191076A1 (en) Prime-boost vaccination strategy
EP3889165A1 (en) Vaccine composition for preventing rabies, and preparation method therefor
WO2007080942A1 (ja) インターフェロンαを含む口腔組成物
JP2017509597A5 (https=)
Monreal-Escalante et al. Genetically-engineered plants yield an orally immunogenic PirA-like toxin from Vibrio parahaemolyticus
US20160120975A1 (en) Fish vaccine
JP2014525745A5 (https=)
EP3732293B1 (de) Optimiertes wirts-/vektorsystem zur erzeugung protektiver mono- und multivalenter subunit-vakzine auf basis der hefe kluyveromyces lactis
WO2014185817A3 (ru) Вакцина для профилактики и лечения ротавирусной инфекции, содержащая гибридный белок в качестве активного агента (варианты)
KR102018707B1 (ko) 돼지 흉막폐렴의 예방 또는 치료용 백신 조성물
KR20230105738A (ko) 당쇄 구조가 변형된 식물로부터 생산된 SARS-CoV-2의 스파이크 단백질의 수용체 결합 도메인 및 이의 용도
KR20120066559A (ko) 돼지 유행성 설사병 바이러스의 에피토프와 로타바이러스 유전자를 발현하는 형질전환체 및 이를 포함하는 백신 조성물
JP2021524273A5 (https=)